How GLP-1 Prescription Renewals Work Online

Legally, there is less difference than the vocabulary suggests: both end with a prescriber signing a new authorization. The difference is the file behind it. A first-time application is assessed cold; a renewal is assessed with history — what was prescribed, when, by whom, and how the file has evolved. That history changes the paperwork you need and sometimes the questions you are asked, but it never changes the gate itself: a licensed clinician reviews, and declines are possible at renewal too. A prescription is not a subscription — no provider can commit to renewing before a clinician has looked.

• New prescription: full intake — identity, health history, current medications, height and weight — screened from scratch against the provider's published intake criteria. Start at the two-minute check.
• Renewal: a follow-up assessment referencing the existing file. Felix describes its renewal as a check-up visit reviewed by a practitioner — "a shortened version of your initial assessment visit" (verified 2026-08-14). The exact question set is not published by any provider, so have your history to hand rather than guessing which parts will be asked for.
• Either way: the provider’s clinician makes the final decision, and the decision is per-application.

Both program providers publish their renewal mechanics, and they run on the same pattern: the platform prompts, the patient completes, a clinician decides. Felix emails you when a prescription is nearing its end and shows a banner on the treatment; you submit the renewal visit yourself, and in this category that visit costs $40 — every time, and separately from whatever the medication costs. Its re-review generally runs about every three months at first and less often afterwards. Hims Canada prompts a follow-up consultation on your patient profile once a prescription is out of refills, and its follow-ups run from $39 up to $99 depending on the treatment. At a visit provider like Maple the shape is simpler: a renewal is another visit at the standard visit price. (All verified 2026-08-14.)

A renewal does not always need an appointment or an online visit. In much of the country a pharmacist can renew an existing prescription for continuity of care — and the provincial rules differ in a way that decides what is actually possible at the counter.

• Ontario: pharmacists may renew a prescription for the purpose of continuity of care, capped at the lesser of the quantity originally prescribed including refills, or a twelve-month supply. They may adapt the dose, formulation, regimen or route — but adapting explicitly does not include substituting a different drug, and they may not renew or adapt a controlled substance or a monitored drug (verified 2026-08-14, Ontario College of Pharmacists; cited on our Ontario page).
• British Columbia: adapting formally includes renewing a prescription, changing the dose, formulation or regimen, and making a therapeutic substitution within the same class — the thing Ontario pharmacists may not do. A renewal there requires a prescription written less than two years ago and a stable, unchanged picture for three to six months, cannot run past the original prescription’s own expiry, and is off the table where the prescriber has handwritten "do not renew/adapt". PharmaCare pays the pharmacist $10 for a renewal and $17.20 for a therapeutic substitution (verified 2026-08-14, Government of British Columbia; cited on our BC page).
• Alberta: pharmacists holding Additional Prescribing Authorization hold authorization from the registrar to prescribe Schedule 1 drugs, which is a wider power than renewal (verified 2026-08-14, Alberta College of Pharmacy; cited on our Alberta page).

Two things bound all of that. First, one class-level fact works in your favour: no semaglutide or tirzepatide record in Health Canada’s Drug Product Database carries a controlled-substance designation (verified 2026-08-14), so the tighter regime that governs those drugs is not what stands in the way. Second, we have verified these rules in three provinces only — for the other seven, and for the territories, the pharmacy counter and your provincial college hold the current answer. A pharmacist also decides case by case; an authority to renew is not an obligation to.

This is the renewal case the online platforms quietly serve well: your Ozempic or Wegovy prescription came from a family doctor you have since lost, a walk-in clinic, or a clinician in a province you have moved away from — and the refills have run out. You do not need the original prescriber’s permission to apply elsewhere. An online provider takes your renewal application as a fresh file with history: the clinician reviews your situation, including the existing prescription, and makes an independent decision.

Whether any provider requests records from your original prescriber, and how prior-prescription details get confirmed, is not something we have verified at any of them — so assume you will be the source of that history and bring it. Two further caveats. First, province still rules: the platform must serve where you live now, and the providers hub sorts that quickly. Second, if the old prescription still has refills left, a transfer may come first — transfers covers moving an active prescription before it lapses.

• The prescription’s paper trail: which product and strength, the prescribing clinician or clinic, and the dispensing pharmacy — enough for a reviewing clinician to reconstruct the history. We have not verified which of these any provider requires at intake, so bring all of them.
• Your current medication list, complete and current — renewals are screened on today's file, not last year's.
• Updated basics: height and weight, and any changes to your health history since the original prescription.
• Identity and address, matching the province you are applying in.
• Your timing math: how much supply remains, so a review period does not leave a gap — running low mid-review is a refill problem, covered at refills.